XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue, net $ 11,965 $ 12,153 $ 37,419 $ 31,214
Costs and operating expenses:        
Cost, Product and Service [Extensible List] Product Product Product Product
Cost of product revenue $ 1,073 $ 1,310 $ 3,528 $ 3,298
Research and development 13,719 12,719 39,919 37,505
Selling and marketing 10,186 9,576 29,390 26,054
General and administrative 8,531 8,077 23,875 24,345
Total costs and operating expenses 33,509 31,682 96,712 91,202
Loss from operations (21,544) (19,529) (59,293) (59,988)
Other income:        
Interest income 285 7 375 27
Interest expense (1,797) (1,658) (5,175) (4,991)
Change in fair value of derivative liability (1,133) 23,837 8,598 62,249
Other income (expense), net 1   (1)  
Total other income, net (2,644) 22,186 3,797 57,285
Net (loss) income $ (24,188) $ 2,657 $ (55,496) $ (2,703)
Net (loss) income per share, basic $ (0.31) $ 0.03 $ (0.72) $ (0.04)
Weighted average common shares outstanding, basic 76,975,839 76,552,060 76,829,434 76,317,563
Net (loss) income per share, diluted $ (0.31) $ (0.23) $ (0.73) $ (0.75)
Weighted average common shares outstanding, diluted 76,975,839 85,446,886 82,598,666 82,086,795
Product        
Revenue:        
Total revenue, net $ 11,913 $ 12,153 $ 36,555 $ 31,214
Collaboration revenue        
Revenue:        
Total revenue, net $ 52   $ 864